About Outruntx
Outruntx is a company based in Dundee (United Kingdom) founded in 2021.. Outruntx has raised $10 million across 1 funding round from investors including M-Ventures and MP Healthcare. Outruntx offers products and services including E3 Ligase Inhibitor Platform. Outruntx operates in a competitive market with competitors including Accutar Biotechnology, Plexium, Photys Therapeutics, Lycia Therapeutics and Uvic Steratics, among others.
- Headquarter Dundee, United Kingdom
-
Sectors
Healthcare
-
Email
***********
-
Phone
*********
-
Website
*********
-
Social
*********
- Legal Name Outrun Therapeutics Limited
- Date of Incorporation 26 Nov, 2019
- Jurisdiction DUNDEE, SCOTLAND
-
Annual Revenue
-
Net Profit
-
EBITDA
-
Total Equity Funding
$10 M (USD)
in 1 rounds
-
Latest Funding Round
$10 M (USD), Seed
Apr 18, 2024
-
Investors
M-Ventures
& 1 more
-
Employee Count
Employee Count
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of Outruntx
Outruntx offers a comprehensive portfolio of products and services, including E3 Ligase Inhibitor Platform. The company's diverse product and service offerings are designed to meet the evolving needs of its customers, address market demands, and provide comprehensive solutions that drive value creation and customer satisfaction across various segments and use cases.
Generates inhibitors for protein stabilisation in cancer treatment.
Funding Insights of Outruntx
Outruntx has successfully raised a total of $10M through 1 strategic funding round. The most recent funding activity was a Seed round of $10 million completed in April 2024. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding Total Funding
- Total Rounds 1
- Last Round Seed — $10.0M
-
First Round
First Round
(18 Apr 2024)
- Investors Count 2
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Apr, 2024 | Amount | Seed - Outruntx | Valuation |
investors |
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Investors in Outruntx
Outruntx has secured backing from 2 investors, including venture fund investors. Prominent investors backing the company include M-Ventures and MP Healthcare. This diverse investor base provides strategic capital, industry expertise, and valuable network connections that support the company's growth initiatives, market expansion, and long-term value creation.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Venture capital firm investing in multiple sectors
|
Founded Year | Domain | Location | |
|
A venture capital firm focused on life science innovations.
|
Founded Year | Domain | Location |
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Single family office of Amitabh Bachchan, founder of Amitabh Bachchan Corporation or AB CORP
|
Founded Year | Domain | Location | |
|
Startup ecosystems are ignited through strategic investments by Signite Partners.
|
Founded Year | Domain | Location | |
|
Venture capital is directed toward companies in multiple sectors.
|
Founded Year | Domain | Location | |
|
Venture capital is invested in cybersecurity, fintech, and AI startups.
|
Founded Year | Domain | Location |
Investments & Acquisitions by Outruntx
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Bionic investment advisor platform
|
2016 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 |
Financial Statements - Outruntx
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Outruntx Comparisons
Competitors of Outruntx
Outruntx operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Accutar Biotechnology, Plexium, Photys Therapeutics, Lycia Therapeutics and Uvic Steratics, among others. This competitive environment drives innovation, market differentiation, and strategic positioning as companies strive to capture market share and deliver value to their customers. Understanding the competitive dynamics is crucial for assessing market positioning, identifying growth opportunities, and navigating the challenges inherent in a competitive marketplace.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
AI-assisted tools for drug discovery are developed.
|
|
| domain | founded_year | HQ Location |
Integrated chemistry service provider
|
|
| domain | founded_year | HQ Location |
Protein-based small molecules are developed to treat human diseases.
|
|
| domain | founded_year | HQ Location |
Protein degradation drugs are developed for cancer and autoimmune diseases.
|
|
| domain | founded_year | HQ Location |
Anti-cancer drugs are developed via Proteolysis Targeting Chimera technology.
|
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Multiple services are booked via an app-based platform.
|
|
| domain | founded_year | HQ Location |
On-demand services are booked through an app-based platform.
|
|
| domain | founded_year | HQ Location |
App based platform offering on demand delivery and ride-hailing services
|
|
| domain | founded_year | HQ Location |
Operates an on-demand hyperlocal delivery app for food and groceries.
|
Latest news on Outruntx
Frequently Asked Questions about Outruntx
When was Outruntx founded?
Outruntx was founded in 2021 and raised its 1st funding round 3 years after it was founded.
Where is Outruntx located?
Outruntx is headquartered in Dundee, United Kingdom. It is registered at Dundee, Scotland, United Kingdom.
Is Outruntx a funded company?
Outruntx is a funded company, having raised a total of $10M across 1 funding round to date. The company's 1st funding round was a Seed of $10M, raised on Apr 18, 2024.
What does Outruntx do?
Outruntx was founded in 2021 and is based in Dundee, United Kingdom. Operations focus on the biotechnology sector, where therapeutics for cancer treatment are developed. A proprietary platform technology is utilized to identify compounds that selectively target the protein degradation pathway protecting tumor suppressors. This approach enables the treatment of cancer through targeted interventions.
Who are the top competitors of Outruntx?
Outruntx's top competitors include Plexium, Photys Therapeutics and Uvic Steratics.
What products or services does Outruntx offer?
Outruntx offers E3 Ligase Inhibitor Platform.
Who are Outruntx's investors?
Outruntx has 2 investors. Key investors include M-Ventures, and MP Healthcare.